INS and diabetes mellitus: Moreover, the higher representativeness of the sample in terms of age, following extension of the study to include subjects aged from 13 to 55 years, would appear to promote extension of validity of the questionnaire to larger samples of adolescent and adult patients affected by insulin-treated diabetes.